Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more
Vaishali Pharma Limited (VAISHALI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.030x
Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has a cash flow conversion efficiency ratio of 0.030x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹20.46 Million) by net assets (₹673.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vaishali Pharma Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Vaishali Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vaishali Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vaishali Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Plaza Centers NV
WAR:PLZ
|
0.001x |
|
Castle Peak Holdings Public Company Limited
BK:CPH
|
0.078x |
|
Terrain Minerals Ltd
AU:TMX
|
-0.113x |
|
Imugene Limited
PINK:IUGNF
|
-0.820x |
|
TVA Group Inc
PINK:TVAGF
|
0.152x |
|
Scandinavian Real Heart AB (Publ)
F:7820
|
-0.026x |
|
Salarius Pharmaceuticals Inc
NASDAQ:SLRX
|
-0.388x |
|
Genesis Fertility Center Public Company Limited
BK:GFC
|
0.022x |
Annual Cash Flow Conversion Efficiency for Vaishali Pharma Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Vaishali Pharma Limited from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹649.16 Million | ₹-180.38 Million | -0.278x | -1575.62% |
| 2024-03-31 | ₹428.39 Million | ₹8.07 Million | 0.019x | -29.31% |
| 2023-03-31 | ₹405.31 Million | ₹10.80 Million | 0.027x | -46.76% |
| 2022-03-31 | ₹263.54 Million | ₹13.19 Million | 0.050x | -44.23% |
| 2021-03-31 | ₹224.19 Million | ₹20.11 Million | 0.090x | -40.41% |
| 2020-03-31 | ₹213.81 Million | ₹32.19 Million | 0.151x | +13.11% |
| 2019-03-31 | ₹213.99 Million | ₹28.48 Million | 0.133x | +128.99% |
| 2018-03-31 | ₹206.02 Million | ₹-94.60 Million | -0.459x | -308.54% |
| 2017-03-31 | ₹38.69 Million | ₹8.52 Million | 0.220x | -84.38% |
| 2016-03-31 | ₹32.54 Million | ₹45.88 Million | 1.410x | +222.75% |
| 2015-03-31 | ₹32.35 Million | ₹-37.16 Million | -1.149x | +49.84% |
| 2014-03-31 | ₹30.74 Million | ₹-70.40 Million | -2.290x | -267.26% |
| 2013-03-31 | ₹27.73 Million | ₹37.97 Million | 1.369x | -- |